Stay updated on RC48-ADC in Advanced Melanoma HER2 Variant Clinical Trial
Sign up to get notified when there's something new on the RC48-ADC in Advanced Melanoma HER2 Variant Clinical Trial page.

Latest updates to the RC48-ADC in Advanced Melanoma HER2 Variant Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedRevision: v3.4.2 was added to the history, and the funding lapse notice and the Revision: v3.4.1 entry were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.9%

- Check21 days agoChange DetectedA government funding notice was added at the top and the record history revision label updated from v3.4.0 to v3.4.1.SummaryDifference0.9%

- Check28 days agoChange DetectedThe update adds a glossary display option, color-coded additions and deletions in the change history, and updates the revision tag to v3.4.0; the previous No FEAR Act data label and revision v3.3.4 are removed.SummaryDifference1%

- Check42 days agoChange DetectedRevision history shows the addition of Revision: v3.3.4 and the removal of Revision: v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check49 days agoChange DetectedRecord History now includes a new entry noting the last known status and sponsor, RemeGen Co., Ltd., with the update date 2023-11 and a verification tag. It also records the recruitment status as Unknown.SummaryDifference0.9%

- Check63 days agoChange DetectedRevision: v3.3.3 was added to the Record History. The HHS Vulnerability Disclosure item and the Revision: v3.3.2 entry were removed.SummaryDifference0.2%

Stay in the know with updates to RC48-ADC in Advanced Melanoma HER2 Variant Clinical Trial
Enter your email address, and we'll notify you when there's something new on the RC48-ADC in Advanced Melanoma HER2 Variant Clinical Trial page.